The field of neuromodulation, or the introduction of nerve stimulation into the central nervous system, peripheral nervous system, autonomic nervous system, or deep cell nuclei of the brain via an imp
Sorin Group SPA has agreed to pay $20 million to Respicardia Inc. for a minority stake in the Minneapolis company and exclusive rights to distribute its remedē sleep apnea device for the next
Click here to receive an email alert any time IN VIVO publishes a quarterly review on device/diagnostics dealmaking. Device Transactions Device companies kicked off 2013 by raising $1.1 billion
As one of the largest and fastest growing segments of the worldwide medical device market, neuromodulation devices are poised to more than double in revenues over the next decade. Although advances in